Selank: Investigating the GABAergic Modulation of Tuftsin Analogues
16th Sep 2026

What You Need to Know About Selank
- Researchers frequently search for Selank to understand how a modified immune peptide can influence calming brain pathways without causing sedation in laboratory models.
- In plain English, Selank acts like a gentle volume dial on the brain's main braking system (GABA) while stopping helpful mood molecules from breaking down too quickly.
- Published studies in rodent models have observed rapid shifts in GABA receptor gene expression and elevated levels of brain-derived neurotrophic factor (BDNF) within hours of exposure.
- Because it bridges immune system fragments with central nervous system signalling, scientists use this heptapeptide to explore the overlap between stress responses and cytokine balance.
How a Modified Immune Fragment Calms Neural Signalling
Selank is a synthetic seven-amino-acid peptide built by adding a three-amino-acid tail to tuftsin, a natural immune fragment found in the body. Published studies show that this small structural tweak allows the molecule to adjust GABA receptor activity and slow the breakdown of natural mood-regulating peptides in the brain.
To understand how Selank works, it helps to look at its parent molecule first. Natural tuftsin is a short chain of four amino acids—threonine, lysine, proline, and arginine—that splits off from an antibody called immunoglobulin G. In nature, tuftsin helps white blood cells recognise and clear out cellular debris, bit by bit. However, natural tuftsin breaks down in the bloodstream within a few minutes because enzymes chop it apart almost immediately. Researchers at the Institute of Molecular Genetics solved this rapid breakdown by attaching three extra amino acids—proline, glycine, and another proline—to the end of the chain. That Pro-Gly-Pro tail acts like a molecular bumper, shielding the peptide from fast-acting enzymes so it stays intact long enough to interact with nervous system receptors.
Once inside a neural research model, Selank targets the gamma-aminobutyric acid system, better known as GABA. Think of GABA as the brain's main brake pedal. When neurons fire too quickly because of stress signals, GABA steps in to slow the electrical traffic down and restore calm focus. Preclinical models demonstrate that Selank acts as an allosteric modulator of GABA-A receptors. Instead of forcing the receptor open on its own, it gently changes the shape of the receptor docking site so that the body's own natural GABA binds more efficiently. Because it adjusts the receptor's sensitivity rather than flooding the synapse, laboratory animals show calm, focused behaviour without losing coordination or falling asleep.
At the same time, Selank slows down the enzymes that chew up enkephalins. Enkephalins are tiny natural peptides that help the nervous system manage stress and keep emotional signals steady. In stressed laboratory models, enzymes called enkephalinases work overtime, clearing these helpful molecules away too fast. By gently holding those enzymes back, Selank allows natural enkephalins to linger longer around the synapses. Published studies also note a quiet conversation between the immune system and the brain here: Selank helps balance cytokine signals like interleukin-6 while nudging up levels of brain-derived neurotrophic factor, or BDNF, which supports everyday synaptic recovery and focus.

Selank
From £16
Supplied as a sealed freeze-dried vial (stable 12–24 months at 2°C–8°C in a standard refrigerator).
Shop Selank →What Preclinical Models Show Across Minutes, Hours, and Days
When scientists introduce selank 5mg into preclinical models, the observed cellular responses unfold in two distinct waves: a fast electrical shift followed by a slower genetic adjustment. Because the heptapeptide is very small and water-soluble, it moves across membranes rapidly in laboratory setups. Within the first five to thirty minutes of a study, researchers record measurable changes in how GABA-A receptors bind their natural ligands. Electroencephalogram readings in rodent models show a quick smoothing out of erratic brain wave patterns, shifting away from stressed, high-frequency spikes toward steady rhythms associated with alert focus.
During the one-to-six-hour window, the story moves from surface receptors into the interior of the cell. Even though the original seven-amino-acid chain begins to split into smaller pieces as enzymes slowly trim it down, the biological signal keeps going. In fact, published studies show that the smaller breakdown fragments—including that tough Pro-Gly-Pro tail—have their own signalling duties. Around three hours after exposure in stressed tissue cultures, researchers measure a clear rise in BDNF messenger RNA inside the hippocampus and frontal cortex. At the same time, blood assays in stressed animal models show that elevated interleukin-6 levels begin dropping back toward baseline, while serotonin and dopamine turnover in the forebrain steadies out.
What happens over multi-day observation windows is where tuftsin analogues really interest molecular biologists. In transcriptomic studies looking at rat brain tissue across twenty-four hours to fourteen days, a single measured level or a repeated daily protocol ratio altered the expression of dozens of genes tied to neurotransmission. Specifically, scientists tracked changes in the messenger RNA coding for GABA receptor subunits, ion channels, and synaptic transport proteins. Unlike heavy synthetic sedatives that cause cells to pull their GABA receptors inside and hide them—a process that leads to tolerance and withdrawal in animal models—Selank did not trigger receptor downregulation over two-week laboratory schedules. Instead, the cells maintained steady receptor numbers on their outer membranes while consolidating memory tasks more cleanly during maze tests.
By week two or three of a standard preclinical protocol, researchers focus on structural and behavioural markers rather than minute-by-minute electrical shifts. Stressed rodents exposed to loud noises or unfamiliar environments in published studies kept up normal exploratory habits and learning speeds when the tuftsin analogue was included in the study design. These longer-term observations point to steady synaptic tissue remodelling and balanced monoamine signalling rather than a temporary chemical mask.
Biochemical Comparison: Selank vs Related Regulatory Peptides
| Peptide | Amino Acid Sequence | Primary Signalling Target | Metabolic Stability Feature | Key Preclinical Observation |
|---|---|---|---|---|
| Selank | Thr-Lys-Pro-Arg-Pro-Gly-Pro (7 AA) | GABA-A receptor allosteric site and enkephalin-degrading enzymes | C-terminal Pro-Gly-Pro motif resists rapid peptidase cleavage | Alters transcription of 45+ neurotransmission genes in rodent frontal cortex within three hours |
| Native Tuftsin | Thr-Lys-Pro-Arg (4 AA) | Neuropilin-1 and macrophage/microglia tuftsin receptors | Rapidly degraded in plasma within minutes by aminopeptidases | Stimulates phagocytosis and immune cell migration in cell culture models |
| N-Acetyl Selank Amidate | Ac-Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH2 (7 AA) | Putative GABAergic and neurotrophin pathways | N-terminal acetylation and C-terminal amidation block exopeptidases | Extended in vitro half-life compared to unmodified heptapeptide chains |
| Semax | Met-Glu-His-Phe-Pro-Gly-Pro (7 AA) | Melanocortin receptors and TrkB/BDNF signalling cascades | Shares the identical C-terminal Pro-Gly-Pro stabilisation tail | Upregulates BDNF mRNA and supports neuronal survival in ischaemic tissue models |
| Glyprolines (PGP) | Pro-Gly-Pro (3 AA) | Collagenase systems and baseline neurotrophin modulation | High intrinsic resistance to gastrointestinal and blood proteases | Acts as an active breakdown fragment that prolongs parent peptide signalling |
Pairing Tuftsin Analogues with Complementary Neuropeptides
In laboratory settings, researchers rarely look at a single pathway in isolation when studying focus, stress adaptation, and neural recovery. Because Selank works primarily through GABAergic allosteric modulation and enkephalinase inhibition, it leaves several complementary pathways open for paired investigation. When scientists design multi-peptide protocols using cognitive research peptides, the most frequent companion molecule in the literature is Semax.
While Selank is built from an immune fragment (tuftsin), Semax is a seven-amino-acid analogue derived from a fragment of adrenocorticotropic hormone (ACTH 4-10), finished with the exact same Pro-Gly-Pro protective tail. Comparing or combining the two in preclinical models gives researchers a two-sided look at neural performance. Where Selank quiets noisy background firing through the GABA brake pedal and steadies emotional signalling via enkephalins, Semax leans into the accelerator by strongly upregulating BDNF, nerve growth factor (NGF), and dopaminergic attention pathways. When evaluated alongside each other in laboratory workflows, Selank provides the calm baseline stability while Semax drives sharper synaptic plasticity and working memory signals. Because both molecules share the C-terminal Pro-Gly-Pro sequence, they dissolve comfortably in the same neutral aqueous buffers without clumping or cross-reacting in solution.
Another pairing that appears in neurobiology discussions involves Selank alongside PE-22-28, a short seven-amino-acid derivative of spadin. PE-22-28 targets TREK-1 potassium channels, which help regulate the resting electrical charge of brain cells and support new cellular growth in the hippocampus. Studying a GABA modulator like Selank alongside a TREK-1 channel blocker allows investigators to watch how inhibitory synaptic signalling and background potassium currents cooperate during cellular recovery from stress.
Some laboratory designs also explore Selank alongside Pinealon, a tiny three-amino-acid peptide (Glu-Asp-Arg) studied for its direct interactions with cellular DNA and oxidative stress protection in ageing neurons. In these combined models, Pinealon addresses cellular energy and antioxidant defences inside the nucleus, while Selank manages the receptor-level conversation out at the synapse. Across all of these combinations, the guiding logic is simple: pair peptides that do not compete for the exact same receptor docking site, allowing each short amino acid chain to handle its own distinct piece of the cellular signalling puzzle.
Reconstitution calculator
Choose a vial mass and a bacteriostatic reconstitution solution volume. The figure is the resulting concentration.
Concentration: 2.50 mg/mL
Per 0.01mL (10µL): 25.0 mcg
Open the full calculatorBacteriostatic reconstitution solutionWhy Salt Removal and Cold Storage Protect Seven Amino Acids
A seven-amino-acid peptide like Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) might look simple on paper, but its short length makes chemical cleanliness doubly important in the lab. Every step of solid-phase synthesis adds one amino acid at a time. If even a tiny percentage of chains miss a proline or hold onto a leftover chemical protecting group, those truncated six-amino-acid fragments end up in the final powder. In a receptor binding assay, a shortened fragment can sit in the GABA-A allosteric pocket without turning the key properly, muddying the data. That is why verifying a batch via High-Performance Liquid Chromatography (HPLC) at 99% purity or higher, paired with Mass Spectrometry to confirm the exact molecular weight of 751.9 Daltons, is the only way to know the vial actually holds pure Selank.
Just as important is what comes off the peptide during final cleanup: trifluoroacetic acid, or TFA. During manufacturing, TFA is commonly used to cleave the finished peptide chain from its resin bead. However, free TFA ions stick tightly to positively charged amino acids like the lysine and arginine sitting right in the middle of Selank's sequence. If leftover TFA stays in the lyophilised cake, it lowers the pH of the solution and irritates delicate neural cell cultures, causing cellular stress that has nothing to do with the peptide itself. High-grade preparation swaps out harsh TFA for a gentle acetate salt counter-ion or removes excess acid through secondary chromatography, keeping the reconstituted liquid friendly to sensitive biological assays.
Once a clean lyophilised puck arrives, temperature control keeps those seven amino acids intact. In its dry, freeze-dried state, the peptide is locked in a stable matrix, though keeping the sealed vial in a freezer at minus 20°C or a laboratory fridge between 2°C and 8°C prevents slow heat breakdown over months. When it is time to prepare a liquid stock using bacteriostatic reconstitution solution, gentle handling is key. Never shake a reconstituted peptide vial like a cocktail shaker; vigorous foaming creates air-water interfaces that pull peptide chains out of their natural shape. Instead, let the liquid trickle down the inside glass wall and swirl slowly until clear. Once mixed into liquid form, store the vial strictly at 2°C to 8°C in the dark, away from fridge door vibrations, to prevent the Pro-Gly-Pro tail from slowly hydrolysing in water.
Frequently Asked Questions
Why do researchers study Selank and its GABAergic modulation?
Researchers study Selank because it acts as a synthetic analogue of the naturally occurring immune peptide tuftsin. In published studies, scientists analyse how this heptapeptide influences gamma-aminobutyric acid (GABA) receptor binding and brain-derived neurotrophic factor expression. This helps laboratory models characterise how short peptides affect calm signalling without causing sedation.
What is the typical timeline observed in Selank laboratory models?
In preclinical models, gene expression shifts and neurotransmitter signalling changes are often measured within thirty to sixty minutes of application. Longer published studies typically track behavioural and neurochemical markers over ten to fourteen days. This timeframe allows researchers to observe both immediate receptor modulation and sustained enzymatic breakdown resistance.
Can Selank be combined with other peptides in research protocols?
Yes, researchers frequently pair Selank with Semax in laboratory models to observe complementary pathways. While Selank is investigated for its influence on GABAergic systems and enkephalin degradation, Semax is typically studied for melanocortin receptor activity. Combining them at a controlled protocol ratio helps scientists map overlapping neurotrophic signalling networks.
How should lyophilised Selank be stored to maintain purity?
Lyophilised Selank should be stored in a freezer at minus twenty degrees Celsius away from bright light to preserve purity. Once mixed with a bacteriostatic reconstitution solution for laboratory testing, the liquid must be kept in a fridge between two and eight degrees Celsius and used within a few weeks.
Bibliography
- Volkova, A., et al. (2016). Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Frontiers in Pharmacology, 7, 31. View published research
- Filatova, E., et al. (2017). GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells. Frontiers in Pharmacology, 8, 89. View published research
- Inozemtseva, L. S., et al. (2008). Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. Doklady Biological Sciences, 421, 241-243. View published research
- Kost, N. V., et al. (2001). Semax and selank inhibit the enkephalin-degrading enzymes of human serum. Bioorganicheskaia Khimiia, 27(3), 180-183. View published research
- Kolomin, T., et al. (2014). The Temporary Dynamics of Inflammation-Related Genes Expression under Tuftsin Analog Selank Action. Molecular Immunology, 58(1), 50-55. View published research
See our UK peptide research guides & COA briefings first in Google Search.
Add Amino Peptides UK as a Preferred Source on Google⚠️ Research Use Only Disclaimer: All peptides and compounds are sold strictly for in-vitro laboratory research purposes only. Not intended for human or veterinary use, not a dietary supplement, and not approved to diagnose, treat, cure, or prevent any disease or condition. For use by qualified researchers in suitably equipped laboratory environments only. Amino Peptides Ltd operates in full compliance with UK MHRA regulations and applicable EU research chemical guidelines.